Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$0.79 - $2.83 $16,279 - $58,317
20,607 New
20,607 $17,000
Q2 2023

Jul 18, 2023

SELL
$2.49 - $20.59 $120,403 - $995,629
-48,355 Reduced 80.95%
11,378 $30,000
Q1 2023

Apr 13, 2023

BUY
$15.95 - $25.18 $788,727 - $1.25 Million
49,450 Added 480.89%
59,733 $1.11 Million
Q4 2022

Jan 23, 2023

BUY
$13.27 - $17.73 $19,135 - $25,566
1,442 Added 16.31%
10,283 $0
Q3 2022

Oct 26, 2022

BUY
$11.4 - $14.6 $40,481 - $51,844
3,551 Added 67.13%
8,841 $115,000
Q2 2022

Jul 25, 2022

SELL
$7.94 - $12.96 $266,529 - $435,041
-33,568 Reduced 86.39%
5,290 $55,000
Q1 2022

May 02, 2022

BUY
$12.02 - $16.79 $15,085 - $21,071
1,255 Added 3.34%
38,858 $467,000
Q4 2021

Jan 28, 2022

BUY
$9.93 - $15.39 $373,397 - $578,710
37,603 New
37,603 $530,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.